Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Recruiting 9Not yet recruiting 5Completed 4Active not recruiting 4Suspended 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1

Conditions

Solid Malignant Tumors 1Sarcoma, Ewing 1Rectal Neoplasms 1Osteosarcoma 1Colorectal Neoplasms 1Bone Neoplasms 1

Interventions

Specimen Handling 218Magnetic Resonance Spectroscopy 194pembrolizumab 185Carboplatin 160Biopsy 129Cisplatin 128Nivolumab 119Paclitaxel 107Cyclophosphamide 104Radiotherapy 99Gemcitabine 96Dexamethasone 86durvalumab 83atezolizumab 70Rituximab 66Radiation 64Lenalidomide 64Doxorubicin 63Pemetrexed 61Bevacizumab 58Etoposide 56Docetaxel 56olaparib 50Ipilimumab 49Fluorouracil 48Taxes 47Prednisone 47Oxaliplatin 46Vincristine 45Cytarabine 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × regorafenib × 90 days × Clear all
NCT04503694 2026-05-22

REGINA

Jules Bordet Institute

Phase 2 Active not recruiting
72 enrolled
Gastrointestinal

Rectal Neoplasms

NCT04787341 2026-05-20

PARERE

Gruppo Oncologico del Nord-Ovest

Phase 2 Active not recruiting
214 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06246643 2026-05-19

A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer Studies

Bayer

Phase 2 Active not recruiting
13 enrolled

Solid Malignant Tumors

NCT05395741 2026-03-25

Regbone

Institute of Mother and Child, Warsaw, Poland

Phase 1/2 Active not recruiting
30 enrolled
Sarcoma

Bone Neoplasms, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡